LINCS MCF 10A Common Project: Fixed-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Repeat performed by Scientist B in 2019 to assess reproducibility. Dataset 1 of 2: Normalized growth rate inhibition values. - Dataset - HMS LINCS Database

LINCS MCF 10A Common Project: Fixed-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Repeat performed by Scientist B in 2019 to assess reproducibility. Dataset 1 of 2: Normalized growth rate inhibition values. - Dataset (ID:20359)

Download: Excel (XLSX), Comma-separated (CSV)

Filter results: >>>>

|<
<<
Previous
Page 2 of 67
Next
>>
>
26 to 50 of 1656 records
per page:

Small Molecule	barcode	cell_count	frac_dead	corpse_count	cell_count_dead	row	column	agent	concentration	role	timepoint	replicate	cell_line	dead_count	fraction_dead	cell_count__time0	dead_count__time0	cell_count__ctrl	dead_count__ctrl	fraction_dead__ctrl	increase_fraction_dead	GRvalue
Alpelisib	180622_BG_6	16116	0.0221	106	252	11	22	Alpelisib	0.316033316	treatment	72	2	MCF10A-GM_2	358	0.0217	832.0	168.3	20016	537.9	0.0261	-0.00439	0.9077
Alpelisib	180622_BG_7	16320	0.0235	86	299	3	4	Alpelisib	0.316033316	treatment	72	2	MCF10A-GM_5	385	0.0230	832.0	168.3	20016	537.9	0.0261	-0.00308	0.9130
Alpelisib	180622_BG_7	16235	0.0178	50	240	6	17	Alpelisib	0.316033316	treatment	72	2	MCF10A-GM_6	290	0.0175	832.0	168.3	20016	537.9	0.0261	-0.00858	0.9108
Alpelisib	180622_BG_8	16017	0.0159	45	211	6	12	Alpelisib	0.316033316	treatment	72	2	MCF10A-GM_8	256	0.0157	832.0	168.3	20016	537.9	0.0261	-0.01039	0.9052
Alpelisib	180622_BG_8	17176	0.0255	42	397	12	22	Alpelisib	0.316033316	treatment	72	2	MCF10A-GM_9	439	0.0249	832.0	168.3	20016	537.9	0.0261	-0.00120	0.9344
Alpelisib	180622_BG_6	19175	0.0244	113	357	7	14	Alpelisib	0.003326667	treatment	72	2	MCF10A-GM_1	470	0.0239	832.0	168.3	20016	537.9	0.0261	-0.00220	0.9814
Alpelisib	180622_BG_6	20639	0.0282	113	473	8	11	Alpelisib	0.003326667	treatment	72	2	MCF10A-GM_2	586	0.0276	832.0	168.3	20016	537.9	0.0261	0.00148	1.0134
Alpelisib	180622_BG_7	18739	0.0227	59	368	3	13	Alpelisib	0.003326667	treatment	72	2	MCF10A-GM_4	427	0.0223	832.0	168.3	20016	537.9	0.0261	-0.00385	0.9715
Alpelisib	180622_BG_7	20195	0.0272	59	492	8	17	Alpelisib	0.003326667	treatment	72	2	MCF10A-GM_5	551	0.0266	832.0	168.3	20016	537.9	0.0261	0.00043	1.0039
Alpelisib	180622_BG_8	20606	0.0246	42	465	11	6	Alpelisib	0.003326667	treatment	72	2	MCF10A-GM_8	507	0.0240	832.0	168.3	20016	537.9	0.0261	-0.00211	1.0127
Alpelisib	180622_BG_8	19276	0.0242	37	431	13	22	Alpelisib	0.003326667	treatment	72	2	MCF10A-GM_9	468	0.0237	832.0	168.3	20016	537.9	0.0261	-0.00242	0.9836
Alpelisib	180622_BG_6	19494	0.0254	49	448	13	15	Alpelisib	0.00998	treatment	72	2	MCF10A-GM_2	497	0.0249	832.0	168.3	20016	537.9	0.0261	-0.00126	0.9885
Alpelisib	180622_BG_6	19108	0.0293	76	486	13	21	Alpelisib	0.00998	treatment	72	2	MCF10A-GM_3	562	0.0286	832.0	168.3	20016	537.9	0.0261	0.00245	0.9799
Alpelisib	180622_BG_8	20727	0.0319	68	595	13	21	Alpelisib	0.00998	treatment	72	2	MCF10A-GM_7	663	0.0310	832.0	168.3	20016	537.9	0.0261	0.00487	1.0153
Alpelisib	180622_BG_8	20045	0.0266	43	491	14	4	Alpelisib	0.00998	treatment	72	2	MCF10A-GM_8	534	0.0259	832.0	168.3	20016	537.9	0.0261	-0.00018	1.0006
Alpelisib	180622_BG_6	19478	0.0250	114	375	13	4	Alpelisib	0.033266667	treatment	72	2	MCF10A-GM_1	489	0.0245	832.0	168.3	20016	537.9	0.0261	-0.00163	0.9882
Alpelisib	180622_BG_6	19006	0.0237	107	346	13	13	Alpelisib	0.033266667	treatment	72	2	MCF10A-GM_2	453	0.0233	832.0	168.3	20016	537.9	0.0261	-0.00285	0.9776
Alpelisib	180622_BG_7	19340	0.0239	53	410	6	7	Alpelisib	0.033266667	treatment	72	2	MCF10A-GM_5	463	0.0234	832.0	168.3	20016	537.9	0.0261	-0.00274	0.9851
Alpelisib	180622_BG_7	18809	0.0250	50	421	14	3	Alpelisib	0.033266667	treatment	72	2	MCF10A-GM_6	471	0.0244	832.0	168.3	20016	537.9	0.0261	-0.00170	0.9731
Alpelisib	180622_BG_8	19475	0.0259	32	473	7	14	Alpelisib	0.033266667	treatment	72	2	MCF10A-GM_8	505	0.0253	832.0	168.3	20016	537.9	0.0261	-0.00085	0.9881
Alpelisib	180622_BG_8	20572	0.0198	61	347	9	15	Alpelisib	0.033266667	treatment	72	2	MCF10A-GM_9	408	0.0194	832.0	168.3	20016	537.9	0.0261	-0.00668	1.0120
Alpelisib	180622_BG_7	19041	0.0193	56	312	9	4	Alpelisib	0.099799999	treatment	72	2	MCF10A-GM_5	368	0.0190	832.0	168.3	20016	537.9	0.0261	-0.00716	0.9783
Alpelisib	180622_BG_7	18683	0.0191	52	306	12	21	Alpelisib	0.099799999	treatment	72	2	MCF10A-GM_6	358	0.0188	832.0	168.3	20016	537.9	0.0261	-0.00732	0.9702
Alpelisib	180622_BG_7	13613	0.0214	70	223	5	13	Alpelisib	0.997999808	treatment	72	2	MCF10A-GM_5	293	0.0211	832.0	168.3	20016	537.9	0.0261	-0.00505	0.8388
Alpelisib	180622_BG_7	12869	0.0225	71	220	4	9	Alpelisib	0.997999808	treatment	72	2	MCF10A-GM_4	291	0.0221	832.0	168.3	20016	537.9	0.0261	-0.00401	0.8164

|<
<<
Previous
Page 2 of 67
Next
>>
>
26 to 50 of 1656 records
per page:

HMS LINCS Project

LINCS MCF 10A Common Project: Fixed-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Repeat performed by Scientist B in 2019 to assess reproducibility. Dataset 1 of 2: Normalized growth rate inhibition values. - Dataset (ID:20359)